Troxacitabine

WikiDoc Resources for Troxacitabine
Articles
Most recent articles on Troxacitabine Most cited articles on Troxacitabine Review articles on Troxacitabine Articles on Troxacitabine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Troxacitabine Images of Troxacitabine Photos of Troxacitabine Podcasts & MP3s on Troxacitabine Videos on Troxacitabine
Evidence Based Medicine
Cochrane Collaboration on Troxacitabine Bandolier on Troxacitabine TRIP on Troxacitabine
Clinical Trials
Ongoing Trials on Troxacitabine at Clinical Trials.gov Trial results on Troxacitabine Clinical Trials on Troxacitabine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Troxacitabine NICE Guidance on Troxacitabine NHS PRODIGY Guidance FDA on Troxacitabine CDC on Troxacitabine
Books
Books on Troxacitabine
News
Troxacitabine in the news Be alerted to news on Troxacitabine News trends on Troxacitabine
Commentary
Blogs on Troxacitabine
Definitions
Definitions of Troxacitabine
Patient Resources / Community
Patient resources on Troxacitabine Discussion groups on Troxacitabine Patient Handouts on Troxacitabine Directions to Hospitals Treating Troxacitabine Risk calculators and risk factors for Troxacitabine
Healthcare Provider Resources
Symptoms of Troxacitabine Causes & Risk Factors for Troxacitabine Diagnostic studies for Troxacitabine Treatment of Troxacitabine
Continuing Medical Education (CME)
CME Programs on Troxacitabine
International
Troxacitabine en Espanol Troxacitabine en Francais
Business
Troxacitabine in the Marketplace Patents on Troxacitabine
Experimental / Informatics
List of terms related to Troxacitabine

Overview

Troxacitabine (brand name Troxatyl) is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.